William D Baird III's Net Worth
$4.55 Million
Who is William D Baird III?
William D Baird III has an estimated net worth of $4.55 Million. This is based on reported shares across multiple companies, which include 2seventy bio, Inc., bluebird bio, Inc., AMICUS THERAPEUTICS INC, and Axcella Health Inc..
SEC CIK
William D Baird III's CIK is 0001547658
Past Insider Trading and Trends
2021 was William D Baird III's most active year for acquiring shares with 19 total transactions. William D Baird III's most active month to acquire stocks was the month of October. 2015 was William D Baird III's most active year for disposing of shares, totalling 15 transactions. William D Baird III's most active month to dispose stocks was the month of December. 2017 saw William D Baird III paying a total of $570,132.00 for 185,720 shares, this is the most they've acquired in one year. In 2017 William D Baird III cashed out on 81,554 shares for a total of $583,791.66, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
2seventy bio, Inc. (TSVT) Snapshot price: $5.5933
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.29% | 56.25K |
—
|
—
| 308.58K |
Apr 1
| |||
Form 4
| +55.08% | 89.62K |
$3.75 | -$5,179.97 | 252.34K |
Jan 5 - Jan 8
| |||
Form 4
| -17.14% | -33.65K |
$3.87 | -$130,178.89 | 162.72K |
Jan 3
| |||
Form 4
| -3.46% | -7.03K |
$5.49 | -$38,575.58 | 196.37K |
Aug 22
| |||
Form 4
| -3.28% | -6.91K |
$6.13 | -$42,304.08 | 203.4K |
Aug 3
| |||
Form 4
| -0.30% | -637.00 |
$12.86 | -$8,191.82 | 210.3K |
Feb 13
| |||
Form 4
| +167.70% | 132.14K |
—
|
—
| 210.94K |
Feb 1
| |||
Form 4
| -1.35% | -1.08K |
$10.63 | -$11,446.46 | 78.8K |
Jan 11
| |||
Form 4
| -3.88% | -3.22K |
$10.33 | -$33,298.40 | 79.87K |
Jan 9
| |||
Form 4
| -4.76% | -4.15K |
$16.23 | -$67,397.34 | 83.1K |
Aug 5
| |||
Form 4
| -4.47% | -4.08K |
$13.81 | -$56,344.39 | 87.25K |
Jul 15
| |||
Form 4
| +58.62% | 33.75K |
—
|
—
| 91.33K |
Mar 1
| |||
Form 4
| -0.74% | -427.00 |
$14.78 | -$6,311.06 | 57.58K |
Feb 17
| |||
Form 4
| -1.52% | -896.00 |
$23.91 | -$21,421.39 | 58.01K |
Jan 7
| |||
Form 4
| +150.85% | 56.23K |
—
|
—
| 93.5K |
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
bluebird bio, Inc. (BLUE) Snapshot price: $0.9319
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +183.93% | 14.77K |
—
|
—
| 22.8K |
Nov 11
| |||
Form 4
| +189.05% | 67.17K |
—
|
—
| 102.7K |
Aug 2
| |||
Form 4
| +64.63% | 13.95K |
$28.16 | -$19,515.78 | 35.53K |
Feb 16 - Feb 17
| |||
Form 4
| -5.33% | -1.22K |
$45.52 | -$55,352.32 | 21.58K |
Feb 12
| |||
Form 4
| -4.00% | -949.00 |
$45.05 | -$42,755.76 | 22.8K |
Jan 6
| |||
Form 4
| +72.75% | 10K |
—
|
—
| 23.75K |
Mar 2
| |||
Form 4
| -8.36% | -1.25K |
$90.60 | -$113,612.40 | 13.75K |
Feb 13
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMICUS THERAPEUTICS INC (FOLD) Snapshot price: $13.005
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$7.34 | -$97,775.00 | 117.62K |
Scheduled
|
Oct 15
| ||
Form 4/A
|
—
|
0
|
$9.04 | -$131,792.00 | 117.62K |
Scheduled
|
Jul 2
| ||
Form 4
|
—
|
0
|
$9.04 | -$131,792.00 | 107.62K |
Scheduled
|
Jul 2
| ||
Form 4
|
—
|
0
|
$8.36 | -$118,148.00 | 245.28K |
Scheduled
|
Apr 2
| ||
Form 4
| +23.66% | 22.5K |
$15.67 | -$114,422.34 | 117.62K |
Jan 3
| |||
Form 4
|
—
|
0
|
$14.72 |
—
| 95.12K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$14.25 |
—
| 95.12K |
Scheduled
|
Oct 12
| ||
Form 4
| -1.60% | -1.55K |
$8.79 | -$13,659.66 | 95.37K |
Jun 15
| |||
Form 4
| +169.61% | 60.98K |
—
|
—
| 96.92K |
Jan 3
| |||
Form 4
| -32.11% | -17.00K |
$8.00 | -$136,074.80 | 35.95K |
Scheduled
|
Sep 20
| ||
Form 4
| +39.53% | 15K |
—
|
—
| 52.95K |
Jun 15
| |||
Form 4
| +477.19% | 31.38K |
$9.03 | -$168,183.75 | 37.95K |
Jan 4
| |||
Form 4
|
—
|
0
|
$16.78 |
—
| 56.58K |
Scheduled
|
Sep 21
| ||
Form 4
|
—
|
0
|
$13.26 |
—
| 56.58K |
Scheduled
|
Jun 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 6.58K |
$10.82 | -$469,959.68 | 6.58K |
Scheduled
|
May 8 - May 11
| ||
Form 4
|
—
|
0
|
$11.51 |
—
| 100K |
Scheduled
|
Mar 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$8.00 |
—
| 100K |
Scheduled
|
Nov 25
| ||
Form 4
|
—
|
0
|
$7.00 |
—
| 100K |
Scheduled
|
Oct 3
| ||
Form 4
|
—
|
0
|
$6.09 |
—
| 100K |
Scheduled
|
Sep 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Apr 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axcella Health Inc. (AXLA) Snapshot price: $0.4009
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||